{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:01:51Z","timestamp":1785178911727,"version":"3.55.0"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T00:00:00Z","timestamp":1480464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371730"],"award-info":[{"award-number":["81371730"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0167120","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T19:24:37Z","timestamp":1480533877000},"page":"e0167120","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["The Effect of Intravenous Immunoglobulin Combined with Corticosteroid on the Progression of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis"],"prefix":"10.1371","volume":"11","author":[{"given":"Liang-ping","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-xing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,11,30]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"S Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.autrev.2008.06.004","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"AT Borchers","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"1\u20132","key":"ref3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3109\/08820538.2015.1114841","article-title":"Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy","volume":"31","author":"VS Chang","year":"2016","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.burns.2015.03.012","article-title":"Complications of Stevens-Johnson syndrome beyond the eye and skin","volume":"42","author":"H Saeed","year":"2016","journal-title":"Burns"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"S Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/BCR.0b013e31815f3865","article-title":"SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center","volume":"29","author":"R Cartotto","year":"2008","journal-title":"J Burn Care Res"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.jid.5700068","article-title":"Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis","volume":"126","author":"S Guegan","year":"2006","journal-title":"J Invest Dermatol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/ijd.12466","article-title":"A clinicotherapeutic analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of SCORe of Toxic Epidermal Necrolysis","volume":"54","author":"S Bansal","year":"2015","journal-title":"Int J Dermatol"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/pde.12481","article-title":"Mycoplasma-associated Stevens-Johnson syndrome in children: retrospective review of patients managed with or without intravenous immunoglobulin, systemic corticosteroids, or a combination of therapies","volume":"31","author":"J Ahluwalia","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/bjd.12607","article-title":"The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre","volume":"169","author":"HY Lee","year":"2013","journal-title":"Br J Dermatol"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2340\/00015555-1169","article-title":"Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes","volume":"92","author":"SK Tan","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2012.10965.x","article-title":"The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"167","author":"YC Huang","year":"2012","journal-title":"Br J Dermatol"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jtos.2015.10.002","article-title":"Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis\u2014A Comprehensive Review and Guide to Therapy. I. Systemic Disease","volume":"14","author":"S Kohanim","year":"2016","journal-title":"Ocul Surf"},{"issue":"6982","key":"ref14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"WH Chung","year":"2004","journal-title":"Nature"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","article-title":"Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population","volume":"20","author":"T Ozeki","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"5388","key":"ref16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"I Viard","year":"1998","journal-title":"Science"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/jid.2012.330","article-title":"TNF-alpha and IFN-gamma are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis","volume":"133","author":"I Viard-Leveugle","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"e45516","DOI":"10.1371\/journal.pone.0045516","article-title":"Recovered patients with Stevens-Johson syndrome and toxic epidermal necrolysis maintain long-lived IFN-gamma and sFasL memory response","volume":"7","author":"M Fu","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.coi.2007.04.007","article-title":"Apoptosis induced by the lymphocyte effector molecule perforin","volume":"19","author":"P Bolitho","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"WH Chung","year":"2008","journal-title":"Nat Med"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood-2009-06-225417","article-title":"Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation","volume":"115","author":"E Aubin","year":"2010","journal-title":"Blood"},{"issue":"13","key":"ref22","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood-2012-07-445007","article-title":"Intravenous immunoglobulin (IVIg) inhibits CD8 cytotoxic T-cell activation","volume":"120","author":"P Trepanier","year":"2012","journal-title":"Blood"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/imm.12189","article-title":"Intravenous immunoglobulin modulates the expansion and cytotoxicity of CD8+ T cells","volume":"141","author":"P Trepanier","year":"2014","journal-title":"Immunology"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.clim.2009.09.006","article-title":"Exposure of NK cells to intravenous immunoglobulin induces IFN gamma release and degranulation but inhibits their cytotoxic activity","volume":"133","author":"C Jacobi","year":"2009","journal-title":"Clin Immunol"},{"issue":"6","key":"ref25","first-page":"743","article-title":"High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases","volume":"20","author":"J Chen","year":"2010","journal-title":"Eur J Dermatol"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.4103\/0378-6323.113080","article-title":"Low dose intravenous immunoglobulins and steroids in toxic epidermal necrolysis: a prospective comparative open-labelled study of 36 cases","volume":"79","author":"S Jagadeesan","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1365-4632.2009.04166.x","article-title":"Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China","volume":"48","author":"Y Yang","year":"2009","journal-title":"Int J Dermatol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/ijd.12423","article-title":"Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies","volume":"54","author":"SJ Barron","year":"2015","journal-title":"Int J Dermatol"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/2042098611404094","article-title":"Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality","volume":"2","author":"JC Roujeau","year":"2011","journal-title":"Ther Adv Drug Saf"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2133.2012.11074.x","article-title":"The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies","volume":"167","author":"HY Lee","year":"2012","journal-title":"Br J Dermatol"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.burns.2006.08.014","article-title":"Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS): experience with high-dose intravenous immunoglobulins and topical conservative approach. A retrospective analysis","volume":"33","author":"M Stella","year":"2007","journal-title":"Burns"},{"key":"ref32","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a 20-year single-center experience","author":"J Lalosevic","year":"2014","journal-title":"Int J Dermatol"},{"issue":"7109","key":"ref33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"JP Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"17","key":"ref36","first-page":"69","article-title":"Analysis on immunoglobulin and corticosteroid combination therapy on pediatric Stevens-Johnson syndrome","volume":"10","author":"X Zhang","year":"2013","journal-title":"World Health Digest"},{"issue":"5","key":"ref37","first-page":"634","article-title":"Clinical observations of the effects of high-dose immunoglobulin and steroid combination therapy on Stevens-Johnson syndrome","volume":"9","author":"TF Jiang","year":"2007","journal-title":"Zhejiang Clin Med"},{"issue":"7","key":"ref38","first-page":"529","article-title":"Clinical analysis on toxic epidermal necrolysis treated by immunoglobulin and corticosteroid combination therapy","volume":"26","author":"M Wang","year":"2010","journal-title":"Chin J Lepr Skin Dis"},{"issue":"6","key":"ref39","first-page":"670","article-title":"Clinical analysis on 35 cases with toxic epidermal necrolysis","volume":"10","author":"ZH Xia","year":"2012","journal-title":"Clin Educ Gen Pract"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1097\/BCR.0b013e318254d2ec","article-title":"Toxic epidermal necrolysis: performance of SCORTEN and the score-based comparison of the efficacy of corticosteroid therapy and intravenous immunoglobulin combined therapy in China","volume":"33","author":"QY Zhu","year":"2012","journal-title":"J Burn Care Res"},{"key":"ref41","first-page":"30","article-title":"High dose immunoglobulin combined with methylprednisolone in the treatment of severe drug eruption clinical observation nursing","volume":"23","author":"Z Dai","year":"2012","journal-title":"J Front Med"},{"issue":"3","key":"ref42","first-page":"139","article-title":"Clinical observations of the effects of immunoglobulin and steriod combination therapy on severe cutaneous adverse reactions","volume":"6","author":"LH Jin","year":"2011","journal-title":"Chin Pract Med"},{"issue":"7","key":"ref43","first-page":"698","article-title":"Clinical analysis of corticosteroid and immunoglobulin combination therapy on severe adverse drug reactions","volume":"26","author":"RR Liu","year":"2012","journal-title":"J Chin Pract Diagn Ther"},{"issue":"2","key":"ref44","first-page":"133","article-title":"Clinical analysis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"16","author":"WS Lu","year":"2013","journal-title":"Chin J Clin Healthc"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.BCR.0000105096.93526.27","article-title":"Toxic epidermal necrolysis: does immunoglobulin make a difference?","volume":"25","author":"KM Brown","year":"2004","journal-title":"J Burn Care Rehabil"},{"issue":"6","key":"ref46","first-page":"430","article-title":"High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis","volume":"83","author":"E Campione","year":"2003","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/00015550510038232","article-title":"Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients","volume":"85","author":"KJ Kim","year":"2005","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.bjps.2004.12.007","article-title":"Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report","volume":"58","author":"M Lissia","year":"2005","journal-title":"Br J Plast Surg"},{"issue":"8","key":"ref49","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2230.2010.03826.x","article-title":"Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre","volume":"35","author":"R Rajaratnam","year":"2010","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archderm.139.1.39","article-title":"Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience","volume":"139","author":"JT Trent","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.139.1.33","article-title":"Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression","volume":"139","author":"N Bachot","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"ref52","first-page":"29","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options","volume":"50","author":"L Teo","year":"2009","journal-title":"Singapore Med J"},{"issue":"5","key":"ref53","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2230.2005.01863.x","article-title":"The timing of intravenous immunoglobulin therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"30","author":"CK Yeung","year":"2005","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaad.2013.05.003","article-title":"Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","volume":"69","author":"RA Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"2\u20133","key":"ref55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12016-014-8418-y","article-title":"Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review","volume":"48","author":"VL Yip","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ophtha.2014.08.013","article-title":"The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome","volume":"122","author":"DH Kim","year":"2015","journal-title":"Ophthalmology"},{"issue":"8","key":"ref57","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.eye.6701653","article-title":"High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits","volume":"19","author":"LW Yip","year":"2005","journal-title":"Eye (Lond)"},{"issue":"5","key":"ref58","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3341\/kjo.2013.27.5.331","article-title":"Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome","volume":"27","author":"KH Kim","year":"2013","journal-title":"Korean J Ophthalmol"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/CCM.0b013e31829eb94f","article-title":"Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation","volume":"42","author":"N de Prost","year":"2014","journal-title":"Crit Care Med"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/bjd.13505","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: follow-up of pulmonary function after remission","volume":"172","author":"TA Duong","year":"2015","journal-title":"Br J Dermatol"},{"issue":"22","key":"ref61","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.2169\/internalmedicine.50.5582","article-title":"Severe obliterative bronchitis associated with Stevens-Johnson syndrome","volume":"50","author":"T Woo","year":"2011","journal-title":"Intern Med"},{"issue":"5","key":"ref62","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"P Sekula","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ref63","first-page":"CD001090","article-title":"3rd. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock","volume":"9","author":"MM Alejandria","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"ref64","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.transproceed.2013.11.100","article-title":"Fourteen successful consecutive cases of ABO-incompatible living donor liver transplantation: new simplified intravenous immunoglobulin protocol without local infusion therapy","volume":"46","author":"JD Kim","year":"2014","journal-title":"Transplant Proc"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"11954","DOI":"10.1111\/bjd.14530","article-title":"Guidelines for the management of Stevens-Johonson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"D Creamer","year":"2016","journal-title":"Br J Dermatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0167120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T03:57:43Z","timestamp":1692590263000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0167120"}},"subtitle":[],"editor":[{"given":"Ying-Ju","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,30]]},"references-count":65,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0167120","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,30]]}}}